ArticleJournal of the American Society of Nephrology : JASN2026

Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk.

Sydney E Hartsell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.